Table 2.
Base-case Analysis for 60-Year-old Patient—Bosniak IIF
| Strategy | Total cost, $ | QALYs | ICERs | |
| 10% Active surveillance | ceCT | 6,460.13 | 8.1897 | – |
| ceUS | 6,576.51 | 8.1924 | 43,168.99 | |
| ceMRI | 7,703.56 | 8.1907 | Dominated | |
| 20% Active surveillance | ceCT | 6,200.30 | 8.1853 | – |
| ceUS | 6,301.35 | 8.1882 | 34,762.32 | |
| ceMRI | 7,540.17 | 8.1837 | Dominated | |
| 50% Active surveillance | ceCT | 5,429.69 | 8.1707 | – |
| ceUS | 5,475.65 | 8.1739 | 14,559.42 | |
| ceMRI | 7,055.89 | 8.1601 | Dominated | |
| 100% Active surveillance | ceUS | 4,098.25 | 8.1498 | – |
| ceCT | 4,138.99 | 8.1460 | Dominated | |
| ceMRI | 6,250.88 | 8.1215 | Dominated |
Abbreviations: ceCT, contrast-enhanced computed tomography; ceMRI, contrast-enhanced magnetic resonance imaging; ceUS, contrast-enhanced ultrasound; ICER, incremental cost-effectiveness ratio; QALY, quality-adjusted life year.